Stay updated on Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Page revision updated from v3.6.0 to v3.6.3, indicating a newer version of the page or its documentation is now in effect. The update appears to affect metadata rather than visible content.
    Difference
    0.0%
    Check dated 2026-06-30T01:11:52.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The page’s Related Topics section has had three items removed: Melanoma, the Related topics header, and MedlinePlus Genetics. This reduces auxiliary links but does not affect the main study details.
    Difference
    0.1%
    Check dated 2026-06-22T22:53:42.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now signals that recruitment has closed ('No longer looking for participants') and adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) along with a revised label for Intervention/Treatment and a version update to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-15T15:47:41.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page's revision is updated from v3.5.4 to v3.5.5, signaling a new build of the page content. The content described in the page remains unchanged.
    Difference
    0.0%
    Check dated 2026-06-08T15:48:58.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Melanoma is added as a condition label and MedlinePlus Genetics is listed under related topics, improving navigation to disease context and genetics resources on the page.
    Difference
    0.1%
    Check dated 2026-05-25T08:23:41.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A new Revision: v3.5.4 tag was added and older items including Melanoma, related topics, MedlinePlus Genetics, and Revision: v3.5.3 were removed, indicating a small site-wide update rather than changes to the trial content.
    Difference
    0.1%
    Check dated 2026-05-18T04:01:09.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.